- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02721316
Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal (SIPRéS)
Randomized Study of Ambulatory Monitoring Nurse Under the Prevention of Recurrent Suicidal
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Main objective: To evaluate the impact of a specific nursing management (personalized and close, through consultation at the hospital, at home or by phone) monitoring in post-hospitalization, the suicide attempt of recurrence and suicidal crisis, in the year following a suicide attempt in patients suffering from a mood disorder (unipolar or bipolar) or reactive depression.
Secondary objectives:
Studying during the year following the suicide attempt index, the impact of this device on:
- The frequency and intensity of suicidal ideation
- the spontaneous use of emergency care
- the death rate from suicide and other causes
- the cumulative duration of hospitalization for suicidal behavior
- The patient's quality of life
- the number of patients lost to at the end of search
Studying patient compliance with intensive nursing monitoring program.
To study the role of the nurse to determine the factors that promote the construction of a therapeutic alliance.
Establish a mapping of needs and resources suicidal patient for nursing care in post-emergency.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient suffering from a mood disorder (unipolar or bipolar) or reactive depression whose reason for hospitalization in the Psychiatric Emergency Unit Post has attempted suicide
Exclusion Criteria:
- Patients with bipolar disorder, current episode manic in
- Patient Hospitalized full-time (for high suicide risk incompatible with an output of emergencies or clinical transfer) within 3-5 days of the TS
- Patient suffering from a somatic pathology associated with the prognosis is committed in the short term.
- Patients suffering from a neurodegenerative pathology of dementia or pre-dementia types.
- Homeless Patient
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Supported with intensive nursing follow
Supported with intensive nursing follow post hospitalization the team of hospital output of the unit to 12 weeks after discharge.
These interviews will be conducted at the hospital, at home or by phone and their pace will be adjusted according to the patient's condition.
The expected duration of close outpatient follow-up is of maximum 3 months.
|
Intensive nursing follow post - hospitalization
|
|
No Intervention: usual care
For control patients, monitoring will be identical to their usual care as part of their pathology.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite suicidal outcome including suicidal attempt recurrence or hospitalization for suicidal crisis or worsening of suicidal ideation
Time Frame: 12 months from EPAC (Emergency Psychiatry and Acute Care) discharge
|
Composite endpoint including any of the following events:
|
12 months from EPAC (Emergency Psychiatry and Acute Care) discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide attempt recurrence
Time Frame: 12 months from EPAC discharge
|
Occurrence of at least one suicide attempt, defined as medically documented or self-reported attempt or death by suicide
|
12 months from EPAC discharge
|
|
Emergency hospitalization for suicidal crisis without attempt
Time Frame: 12 months from EPAC discharge
|
Occurrence of at least one emergency hospitalization for suicidal crisis, defined as persistent and high-intensity suicidal ideations
|
12 months from EPAC discharge
|
|
Worsening of suicidal ideations
Time Frame: 3 months, 6 months and 12 months after EPAC discharge
|
Increase ≥2 points on the C-SSRS severity score compared with EPAC discharge
|
3 months, 6 months and 12 months after EPAC discharge
|
|
Frequency of suicidal ideation
Time Frame: At inclusion, at EPAC discharge, and at 3 months, 6 months and12 months after EPAC discharge
|
Frequency of suicidal ideation measured with the C-SSRS (Columbia-Suicide Severity Rating Scale).
|
At inclusion, at EPAC discharge, and at 3 months, 6 months and12 months after EPAC discharge
|
|
Intensity of suicidal ideation
Time Frame: At inclusion, at EPAC discharge, and at 3 months, 6 months and 12 months after EPAC discharge
|
Intensity of suicidal ideation measured with the C-SSRS (Columbia-Suicide Severity Rating Scale).
|
At inclusion, at EPAC discharge, and at 3 months, 6 months and 12 months after EPAC discharge
|
|
Psychological pain
Time Frame: At inclusion, at EPAC discharge, and at 3 months, 6 months and 12 months after EPAC discharge
|
Psychological pain measured with Visual Analog Scale (VAS)
|
At inclusion, at EPAC discharge, and at 3 months, 6 months and 12 months after EPAC discharge
|
|
Number of unscheduled healthcare visits for suicidal ideation
Time Frame: At 3 months, 6 months and12 months after EPAC discharge
|
At 3 months, 6 months and12 months after EPAC discharge
|
|
|
All-cause mortality and mortality by suicide
Time Frame: At 3 months, 6 months and12 months after EPAC discharge
|
At 3 months, 6 months and12 months after EPAC discharge
|
|
|
Total duration of psychiatric hospitalization during the year following the suicide attempt
Time Frame: At 3 months, 6 months and12 months after EPAC discharge
|
At 3 months, 6 months and12 months after EPAC discharge
|
|
|
Number of participants lost to follow-up at the end of the study
Time Frame: At 12 months after EPAC discharge
|
At 12 months after EPAC discharge
|
|
|
Patient quality of life
Time Frame: At inclusion, at 3 months, 6 months and12 months after EPAC discharge
|
At inclusion, at 3 months, 6 months and12 months after EPAC discharge
|
|
|
Adherence to the therapeutic program proposed and/or prescribed in the service.
Time Frame: 12 months after EPAC discharge
|
12 months after EPAC discharge
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Grégory Mykolow, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UF9533
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mood Disorder
-
Queen's UniversityCompleted
-
Bard CollegeCompletedMajor Depressive Disorder | Low MoodUnited States
-
Shanghai Mental Health CenterEnrolling by invitationBipolar Disorder;Major Depressive Disorder;Mood DisordersChina
-
Spectrum Health - LakelandCompletedSeasonal Mood DisorderUnited States
-
Tri-Service General HospitalMinistry of Science and Technology, TaiwanCompletedDisruptive Mood Dysregulation Disorder
-
Weill Medical College of Cornell UniversityCompleted
-
National Institute of Mental Health (NIMH)Completed
-
University of MichiganEnrolling by invitationPhysical Activity | Sleep | Mood | Depression - Major Depressive DisorderUnited States
-
The Hong Kong Polytechnic UniversityCommunity Psychiatric Service, Castle Peak Hospital, Tuen Mun, Hong Kong.CompletedDepression | Major Depressive Disorder | Mood DisorderHong Kong
-
Rigshospitalet, DenmarkRecruitingMajor Depressive Disorder | Sexual Behavior | Mood Change | Mood Disturbance | Affect Altered | Affect Blunted | Drug MechanismDenmark
Clinical Trials on Supported with intensive nursing follow post hospitalization
-
Corporacion Parc TauliHospital Son Espases; Fundació La Marató de TV3; Universitat de les Illes BalearsActive, not recruitingPost Intensive Care Syndrome | ICU Survivors | ICU FamiliesSpain
-
Rabin Medical CenterUnknown
-
Istanbul University - Cerrahpasa (IUC)Active, not recruitingQuality of Life | Multiple Sclerosis | Fatigue | Sleep HygieneTurkey
-
Maastricht University Medical CenterCompletedLocally Advanced Rectal CancerNetherlands
-
Institute of Psychiatry and Neurology, WarsawUnknown
-
Umeå UniversityKarolinska Institutet; Uppsala University; The Swedish Research Council; Göteborg... and other collaboratorsRecruiting
-
Laval UniversityUnknownEmergencies | Frailty | Health Care Utilization | TransitionCanada
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
Corporació de Salut del Maresme i la SelvaConsorci Sanitari de TerrassaRecruitingHeart Failure | Chronic Obstructive Lung Disease (COLD)Spain
-
Providence Health & ServicesPatient-Centered Outcomes Research Institute; Oregon Health and Science University and other collaboratorsUnknown